Another example of an unclassified subset is the CD3− CD68+ CD4+ GrB+ cell population, which is higher in cHL patients who respond to anti-PD-L1 therapy and in healthy donors than in newly diagnosed patients [29]. The gene discussed is GZMB; the disease is classic Hodgkin lymphoma.